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Abstract
Background: The reliability of spatial statistics is often put into question because real spatial variations may not
be found, especially in heterogeneous areas. Our objective was to compare empirically different cluster detection
methods. We assessed their ability to find spatial clusters of cancer cases and evaluated the impact of the
socioeconomic status (e.g., the Townsend index) on cancer incidence.
Methods: Moran’s I, the empirical Bayes index (EBI), and Potthoff-Whittinghill test were used to investigate the
general clustering. The local cluster detection methods were: i) the spatial oblique decision tree (SpODT); ii) the
spatial scan statistic of Kulldorff (SaTScan); and, iii) the hierarchical Bayesian spatial modeling (HBSM) in a univariate
and multivariate setting. These methods were used with and without introducing the Townsend index of
socioeconomic deprivation known to be related to the distribution of cancer incidence. Incidence data stemmed
from the Cancer Registry of Isère and were limited to prostate, lung, colon-rectum, and bladder cancers diagnosed
between 1999 and 2007 in men only.
Results: The study found a spatial heterogeneity (p < 0.01) and an autocorrelation for prostate (EBI = 0.02; p = 0.001),
lung (EBI = 0.01; p = 0.019) and bladder (EBI = 0.007; p = 0.05) cancers. After introduction of the Townsend index,
SaTScan failed in finding cancers clusters. This introduction changed the results obtained with the other methods.
SpODT identified five spatial classes (p < 0.05): four in the Western and one in the Northern parts of the study area
(standardized incidence ratios: 1.68, 1.39, 1.14, 1.12, and 1.16, respectively). In the univariate setting, the Bayesian
smoothing method found the same clusters as the two other methods (RR >1.2). The multivariate HBSM found a
spatial correlation between lung and bladder cancers (r = 0.6).
Conclusions: In spatial analysis of cancer incidence, SpODT and HBSM may be used not only for cluster detection
but also for searching for confounding or etiological factors in small areas. Moreover, the multivariate HBSM offers a
flexible and meaningful modeling of spatial variations; it shows plausible previously unknown associations between
various cancers.
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Background
Statistical methods that assess the impact of a spatial
structure on the occurrence of a particular health event
have been developed in many areas over the recent
decades [1]. These methods allow detecting clusters of
disease cases and mapping observations or estimations
[2]. They combine techniques from geography, epide-
miology, and public health to better understand health
needs and allocate resources.
Currently, various epidemiological information systems
are used to collect and analyze health-related data and
guide political decisions. In France, cancer cases are
collected by the Institut National de Veille Sanitaire and
the Institut National du Cancer in collaboration with
Francim network of cancer registries [2]. Mapping cancer
cases may have a significant impact on the perception of
excess rates in particular regions, but the heterogeneity
in population density between administrative areas may
affect the interpretation of mapping results, especially in
case of small areas [3]. To display this heterogeneity, maps
may be produced by operating transformations that better
reflect the spatial distribution of the disease [1]. Still,
whatever the parametric or non-parametric method used
to account for uncertainty in the spatial distribution of the
disease, the choice of the measure to be shown remains a
key issue [4].
In a given geographical area, some health indicators
may reveal an excess number of cases. This excess is
often estimated by the standardized incidence ratio (SIR)
[5]. Generally, the SIR estimates the risk of disease in
a given spatial unit and depends on the existence of
either a spatial autocorrelation (i.e., lack of indepen-
dence between observations) or a spatial heterogen-
eity. Comparisons of SIRs between neighboring spatial
units may suggest grouping sets of spatial units into
classes or clusters.
Two types of methods may be used to detect disease
clusters; i.e., aggregates of cases [6]. Local methods
are able to detect and locate clusters with or without a
predetermined source point. In addition to spatial loca-
tion, some local methods allow for confounding factors
that may affect the spatial distribution of the disease [7].
Global methods look for the presence –but not the loca-
tion– of a clustering pattern [8, 9]. For example, Moran’s
autocorrelation coefficient is a global method that mea-
sures the spatial autocorrelation weighted by a function of
the distance between two close points defined by their
centroids (“average X, average Y”) [10].
Several local detection methods allow identifying clus-
ters with particular shapes within the study area: i)
the spatial scan statistic of Kulldorff (SaTScan) [11]
performs one or several circular or elliptic scans; (ii)
regression trees such as Spatial Oblique Decision Tree
(SpODT) perform oblique cuts; and, iii) hierarchical
Bayesian spatial modeling (HBSM) [4] produces a real
smoothing of the SIR. Many Bayesian applications have
been already used in infectious diseases and cancer; they
were able to distinguish random fluctuations from true
changes in the incidence of the disease.
The first applications of SpODT were made in the
field of infectious diseases; they contributed to the detec-
tion of spatial classes, for example, different risks of
malaria in a Malian village [12] and a spatial pattern of
Buruli disease in Cameroon [13]. In comparison with
SaTScan and classification regression trees (CART),
SpODT provided complementary information, and, in
some cases, was more accurate [12, 14]. However, SpODT
has never been applied to detection of clusters of cancer
cases.
Concerning the geographic distribution of cancer
cases, spatial clustering seems to exist in lung, prostate,
bladder, and colon-rectum cancers but this clustering
depends mainly on the available data [15–18]. Further-
more, the clustering of cancer in a given area may
depend on factors such as the socioeconomic status
[19] and on unknown risk factor common to other
diseases [20].
The main objective of the present study was to com-
pare empirically different cluster detection methods by
assessing their abilities to find spatial clusters of cancer
cases. Secondarily, the study aimed also to evaluate the
impact of the Townsend index of socioeconomic status
on cancer incidence.
Using global detection methods with data on four
cancers, we sought first, for the presence of particular
spatial patterns. Then, we compared the results with
those obtained with local methods (SaTScan, SpODT,
and HBSM) with and without taking into account a
confounding factor; the Townsend index. Thereafter,
we compared the abilities of the three approaches to
estimate random changes in the incidence of each cancer.
Finally, using a multivariate HBSM, we examined whether
factors common to the four cancers could increase the
reliability of the results.
Methods
Population and area
Incident cancer cases diagnosed between 1998 and 2007
were all extracted from the Cancer Registry of Isère (for
more details on this registry, see Ref. [5]). The study
considered only prostate, lung, colon-rectum, and blad-
der cancers in men. The confounding factor was the
Townsend index of deprivation, an indicator of socio-
economic disadvantage. This index is a synthesis of the
following variables: proportion of unemployed people in
the workforce, proportion of households without car,
proportion of households renting, and the proportion of
overcrowded households. This index increases with the
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increase in the level of deprivation [14, 21]. The spatial
unit was the Commune; i.e., the smallest administrative
unit in France (mean number of inhabitants: 1700 over
France, 2300 over Département Isère in 2006) [22].
Statistical analysis strategy
First, we searched for the presence of spatial heteroge-
neity using the Potthoff-Whittinghill method [23–25].
Briefly, if there is no clustering, the observed number
of cases in a geographical area should follow a Poisson
distribution (mean = variance = expected number of cases
in the area). The Potthoff-Whittinghill test checks
whether the ratio of the variance to the expected number
of cases is >1, in which case the data are said over-
dispersed relative to the Poisson distribution (See further
details below).
The “naive” global spatial autocorrelation was checked
using Moran’s I statistic and the “true” global spatial
autocorrelation was confirmed using the Empirical Bayes
Index. Another way to measure the spatial effect or
the spatial correlation in each cancer type was to compare
the goodness of fit between spatial and non-spatial regres-
sion models. For this, we used two non-spatial models,
the Poisson regression and the constant risk model.
Thereafter, we used spatial heterogeneity, autocorrelation,
and Besag-York-Mollié (BYM) models in a Bayesian
approach [26]. We also used SaTScan and SpODT to
explore their abilities to detect spatial clusters in different
scenarios (homogeneity, heterogeneity, spatial autocorre-
lation and the latter two) also detected by global detection
methods. The Townsend socioeconomic index was then
introduced into the modeling of all local detection
methods in the univariate setting to assess its impact
on the spatial distribution of each cancer type. Finally,
we used a multivariate Bayesian modeling to assess
the impact of underlying correlations between the four
cancers on their incidences.
Statistical analysis
Poisson non-spatial regression model
Poisson regression model assumes that Oi|θi ∼ Poisson(Eiθi);
Oi being the number of cases, θi the relative risk, and Ei
the expected number of cases in a given area i. The
SIR is the maximum likelihood estimator of θi and is given
by SIRi ¼ Y i=Ei . The variance of this model,
SIRi=Ei is large
when Ei is small, which reflects an over-dispersion of
cases. The Poisson model assumes also that log θið Þ ¼ log
Eið Þ þ βX i; X being a covariate and β its effect.
Incidence data regarding the four cancer types were
first fitted with Poisson regression and using the add-
itional information on the socioeconomic status.
Global detection method
The global spatial autocorrelation analysis was carried
out by type of cancer using Moran’s I statistic and
the Empirical Bayes Index (EBI), an adapted Moran’s I
proposed to take into account a heterogeneity in popula-
tion distribution.
EBI ¼ NX
wij
X
wijzizjX
zi−zð Þ2
where N is the number of Com-
munes, zi ¼ pi−bffiffiffivip . and pi ¼
Oi
xi
, Oi being the number of
cases and xi the population at risk in Commune Ci;
vi ¼ aþ bxi
 
; b ¼ Ox ; a ¼ s2− bx
Nð Þ ; s
2 ¼
X
xi
pi−bð Þ2
x .
Spatial heterogeneity was tested with Potthoff-
Whittinghill method, the null hypothesis being that the
numbe observed cases Oi. in a Commune Ci is Poisson
distributed and the mean being the number of expected
cases Ei. The test statistic may be written as follows:
PW ¼
XN
i
Oi Oi−1ð Þ
Ei
which is asymptotically normally
distributed, with mean Oþ Oþ−1ð ÞEþ and variance 2ðN−1Þ
OþðOþ−1Þ
ðEþÞ2 and where N is the number of Communes
Ci,O+ = ∑i = 1
N Oi, and C+ = ∑i = 1
N Ci.
Moran’s I and Potthoffhittinghill statistics were
computed using Monte-Carlo simulations with 999
replications [14] under the assumption of multinomial
distribution of cancer cases. The EBI value was tested
using 999 random permutations. Considering the Com-
mune as the spatial unit, three clustering methods were
investigated and compared: SpODT, SaTScan, and HBSM.
SpODT method
This is a non-parametric regression model (similar to
the Classification and Regression Tree (CART) algorithm
of Breiman [12]) that allows local detection of clusters.
However, whereas CART provides perpendicular area
cuts, SpODT provides oblique area cuts which are more
suitable for spatial epidemiology [12, 27]. The functional
form of the SpODT model is zi = f(xi, yi) + εi. In this
formula, {xi, yi} correspond to the Commune centroids
and εi ∈ ℝ represents the residuals. The functional form
f(xi, yi) may be written:
f xi; yið Þ ¼
XP
j¼1
zj I Mi xi; yið Þ∈class jf g
where class j (j = 1,…, P) corresponds to one of the
final P classes after splitting the area under study. For
each point Mi in the j
th class, zj is the mean of the SIR
values of all spatial units and zi ¼ zj  εi is the predicted
risk.
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SpODT algorithm makes recursively oblique cuts of
the study area according to the overall interclass vari-
ance until reaching a final number P of areas as per the
stopping criteria of the algorithm. Once the classification
is obtained, a test is performed using a Monte-Carlo
approach to compare the distribution with the estimated
R2 [27]. For application to our data, we conducted a
sensitivity analysis by changing the values of the para-
meters that serve as stopping criteria for the SpODT
algorithm without using additional information on the
socioeconomic status. After the univariate analysis, a
multivariate analysis was performed and the SIRs of the
detected patterns were those with p-value ≤0.05. After-
wards, we conducted further analyses, first varying the
graft level setting to gather the adjacent final classes
according to their similarity in terms of risk level, then
adding the Townsend index to the model.
SaTScan
This method derives from the Geographical Analysis
Machine (GAM) [28]. It aims at grouping neighboring
spatial units into potential clusters through circular or
elliptical windowing that scans the study area [11].
The observed number of cases is compared with the
expected number inside and outside each window by
computing, for each scan, a likelihood ratio statistic.
Assuming that the observed data follow a Poisson
model, the likelihood ratio is:
L Zð Þ
L0
¼
nz
u zð Þ
 nz N−nz
N−u zð Þ
 N−nz
N
u Að Þ
 N
In this formula, nz and u(z) are the observed and
expected numbers of cases in a circular frame Z, N and
u(A) the observed and expected numbers of cases esti-
mated under the null hypothesis of a homogeneous risk
over the whole area, and nz>u(z) or equal to
1
L0
. In the
present study, we considered only circular windows
because they detect smaller and more compact clusters
than elliptical ones [29]. We conducted a sensitivity
analysis with different maximum cluster sizes for the
at-risk population; precisely, 1 to 50 % of the whole
population. The analyses were performed with and with-
out additional information on the socioeconomic status.
The candidate clusters and their relative risks (RR) were
those with a p-value ≤0.05 as obtained by Monte-Carlo
simulation.
Univariate HBSM
This approach aims at modeling the spatial distribution
and estimating the relative risk (θi) at each spatial unit i.
This approach allows taking into account spatial and
non-spatial effects as structured information that can
be graphically represented by four levels. The first
level represents the local variability inside each spatial
unit as provided by the observed data assumed having
a Poisson distribution; this level gives the likelihood.
The second level (or spatial process level) represents
the variability between spatial units and depends on the
presence of an autocorrelation Uð Þ or a spatial heteroge-
neity Vð Þ . At this level, potential covariates Xð Þ are
assumed to be normally distributed. The third level
(or priors) represents the variability of the spatial process
components and is approached with a particular distribu-
tion (Beta, Gamma, Dirichlet, or Wishart) [30]. Here, a
gamma distribution was chosen for precision (inverse of
the variance). The parameters (called hyperparameters) of
this distribution are fixed a priori according to previous
recommendations [31]; they represent the fourth level.
These hyperparameters were estimated using MCMC
sampling and approximation methods.
Three a priori assumptions on the spatial process level
were tested: i) autocorrelation with conditionally auto-
regressive model (CAR model), analytically written log
θið Þ ¼ αþ U i ; ii) heterogeneity with log θið Þ ¼ αþ V i ;
iii) both, with log θið Þ ¼ αþ U i þ V i according to the
BYM model [26].
In the spatial process, the hypothesis of a homoge-
neous risk was tested with log(θi) = α, which corresponds
to the intercept [4, 5, 32]. Analyses were then performed
using the additional information on the socioeconomic
status X ið Þ with each previous model. In the BYM, this
additional variable was written: log θið Þ ¼ αþ β  X i
þ U i þ V i.
To measure the influence of the socioeconomic status
on the spatial distribution of cancer cases, we compared
the models according to two criteria: i) the empirical
variance of the autocorrelation components S2U ; and, ii)
heterogeneity components S2V and their Deviance Infor-
mation Criterion (DIC) [33]. A comparison was made
between the DIC in each cancer type to identify the
advantages of using a Bayesian approach. As in Colonna
and Sauleau [4, 5, 32], we considered that a DIC diffe-
rence of more than 10 points indicates the presence of
an influence of the socioeconomic status on the diffe-
rences in cancer incidence. The presence of either auto-
correlation or heterogeneity was decided according to
the model that had the highest empirical variance.
Multivariate HBSM
In the multivariate disease mapping, we can assume that,
similarly to the univariate HBSM, the data are structured
into spatial and non-spatial effects and can be graphi-
cally represented by the same four levels. The first level
represents the local variability within each spatial unit as
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provided by the observed data assumed to have a Poisson
distribution:
Oij
θij∼Poisson Eijθij
 
Oij being the number of cases, θij the relative risk, and
Eij the expected number of cases, all in a given area i
and for disease j.
The main difference with the univariate disease map-
ping concerns the second level that represents the vari-
ability between spatial units and assumes a plausible
dependence between diseases [34]. The a priori assump-
tion considers that U or V follow a multivariate normal
distribution (MVN) [35], that can be identified by bb
and analytically written: b ~MVN(0,Σb), where Σb denotes
the variance of parameter also known as the between-
disease covariance matrix. To provide the log relative risks
θij, Martinez-Beneito et al. [20] have recently proposed
two M-based models that unified the multivariate disease
mapping by considering Σb =M
⊺M. One M-based model
considers M as a fixed effects; the other considers them as
random effects of the correlations between the diseases.
The model can be written: log(θij) =ΦM where Φ is the
matrix that contains the distribution of the underlying
spatial patterns. For disease j and area i, log(θj) =Φ1M1j +
… +ΦiMij, where Mij is the entry in M. When Φ follows
three independent proper CAR distributions with different
parameters, the M-based model is equal to the MCAR
model proposed by Jin et al. [36] and equal to that of
Gelfand and Vounatsou [37] in the case of two diseases.
For brevity, we have applied a BYM spatial structure on
four underlying factors (four diseases). This multivariate
BYM model [26] assumes the presence of eight underlying
patterns, four of them with spatially heterogeneous distri-
butions and four with CAR distributions.
Finally, we compared the DICs of the independent
Bayesian modeling in each cancer type with those of the
multivariate BYM models to check the usefulness of the
multivariate approach.
Statistical software programs
Moran and Potthoff-Whittinghill statistics were computed
using package DCluster of R 3.0.2. EBI was computed
using package spdep of R [38]. The proximity-weighted
matrix wij = exp(−dij), a negative exponential function
for exponential decay, was used in all three methods
[9, 39, 40]. For the SpODT, we used version 0.9 of
SpODT package [12, 27]. For SaTScan, we used SaTScan
version 9.3 [11]. For HBSM and Poisson regression, we
used WinBUGS version 1.4.3 to estimate the Bayesian
parameters. More specifically, we called WinBUGS
from R using package R2WinBUGS 2.1-19 [41]. For each
model, we ran three chains. A burn-in of 60 000 iterations
was performed and the posterior distribution was obtained
using a sample of 20 000 iterations. Convergence was
monitored graphically using time series plots checked with
Monte-Carlo standard error [4].
Results
In 2007, the population of Département Isère was
1,178,701 inhabitants. In 2007 too, among the 533 stu-
died Communes, 55.16 % had fewer than one thousand
inhabitants, 33.58 % had 1000 to 4000 inhabitants, and
11.26 % had more than 4000 inhabitants. In these Com-
munes, 3898 cases of lung cancer, 8403 cases of prostate
cancer, 3084 cases of colon-rectum cancer, and 1247
cases of bladder cancer were diagnosed between 1998
and 2007. In Département Isère, the median Townsend
index was -0.002 (range: -10.5 to +7.6, Fig. 1).
Results of the univariate analysis
Lung cancer
Spatial heterogeneity (p = 0.001) without “naive” spatial
autocorrelation (I = 0.001, p = 0.874) or “true” spatial
autocorrelation (EBI = 0.01, p = 0.019) was found for
lung cancer (Table 1). Used without covariate, SpODT
algorithm did not detect significant clusters of lung
cancer (p = 0.5); however, SaTScan algorithm detected
two significant clusters (RR = 1.48, p < 0.0001 and RR =
1.73, p < 0.001) (Fig. 2c). The Poisson model had the
greatest DIC, which shows an over-dispersion of cases
(Tables 2 and 3). The best Bayesian model applied to
lung cancer data without covariate was the BYM model
(Additional file 1: Figure S1a). The empirical variance
of the U component was larger than that of the spatial
heterogeneity V (Table 2).
Fig. 1 Choropleth map of the Townsend index of socioeconomic status
in Département Isère according to the quintiles of its distribution
(light and dark blue for low and high levels of deprivation, respectively)
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With the Townsend index of socioeconomic status
as covariate, SpODT and SaTScan algorithms did not
detect significant high-risk clusters. The DICs and
variances sv
2 and su
2 of the Bayesian models (RR >1.05)
are shown in Table 2. The use of the Townsend index
decreased sharply the DIC as well as variances sv
2 and
su
2 (Table 2). The socioeconomic inequalities seemed
to increase the spatial variations of lung cancer inci-
dence (β = 0.067 [0.054; 0.080]) (Table 4).
Prostate cancer
A Spatial heterogeneity (p = 0.001) with “naive” autocor-
relation (I = 0.01, p = 0.001) and “true” autocorrelation
(EBI = 0.02, p = 0.001) were found with prostate cancer
data (Table 1). The SpODT algorithm cut out the
geographical area into eleven zones with different risk
levels (p < 0.0001). The mapping of these zones identified
six high-risk clusters located at the boundaries of the
study area; precisely, four clusters in the Northwestern
part (SIRs = 1.68, 1.39, 1.14, and 1.12), a fifth at the
Southern part (SIR = 1.16), and a sixth in the Northern
part (SIR = 1.04) (Fig. 3a).
SaTScan located a main cluster of prostate cancer
cases at the center of the area (RR = 1.51, p < 0.0001).
In addition, four other significant clusters were located at
the boundaries of the study area (RR = 1.31, p < 0.0001;
RR = 2.16, p < 0.0001; RR = 1.20, p < 0.0001; and RR = 1.98,
p < 0.01) (Fig. 3b) The Poisson and the constant risk
models had the highest DICs, which reveal an over-
dispersion of cases (Tables 2 and 3). The CAR model was
Table 1 “Naive” spatial autocorrelation (Moran I), “true” Spatial
autocorrelation (EBI), and heterogeneity (Potthoff-Whittinghill)
test results
Cancer Moran I EBI Potthoff-Whittinghill
Lung 0.001 (0.874) 0.01 (0.019) (0.001)
Prostate 0.01 (0.001) 0.02 (0.001) (0.001)
Colon-rectum 0.0004 (0.169) 0.007 (0.446) (0.247)
Bladder 0.001 (0.346) 0.007 (0.05) (0.003)
The results are expressed as: test statistic (p-value)
a b
dc
Fig. 2 Clusters of lung cancer cases found by different methods: a geographic variations of standardized incidence ratio, b Mapping of the log
relative risks by the CAR model using hierarchical Bayesian spatial modeling without adjustment on the Townsend index of socioeconomic status,
c SaTScan clusters of high risk without adjustment on the Townsend index, d Mapping of the log relative risks by the heterogeneity model using
hierarchical Bayesian spatial modeling without adjustment on the Townsend index. Four risk levels were considered (lightest to darkest color)
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the best among the Bayesian approaches (Table 2). Unlike
the heterogeneity model (Fig. 4c), mapping the relative
risk according to BYM (Fig. 3c) and CAR (Fig. 4b) models
showed an over-incidence (RR >1.2) of prostate cancer
and clusters in the study area.
With the Townsend index as covariate, SaTScan de-
tected no clusters whereas SpODT located five clusters
(p < 0.005) in the Northwest of the area; it merged only
the clusters previously found in the Northwestern and
Southern parts of the study area (SIR = 0.93) (Fig. 3d).
There was also no change in the DIC and variances
sv
2 and su
2 remained stable. The CAR model showed that
the socioeconomic inequalities had a slight impact on
the spatial variations of prostate cancer (β = -0.012
[-0.022; -0.001]) (Table 4).
Colon-rectum cancer
The analysis found neither heterogeneity nor spatial
autocorrelation (Table 1). SpODT detected no significant
clusters (p = 0.19). SaTScan detected two clusters (RR =
1.28, p < 0.001 and RR = 1.44, p < 0.001) (Fig. 5c). The
Poisson and all the Bayesian models had the same
DIC, which shows a homogeneous distribution of colon-
rectum cancer cases (Table 2). Mapping the relative risk
according to CAR model (Fig. 5b; Additional files 1–6)
showed a homogeneous risk over the study area.
With the Townsend index, neither SpODT nor SaTScan
could detect significant clusters and the results of Bayesian
modeling did not change (Table 3). With the Bayesian
model, the credible intervals and variances sv
2 and su
2 were
stable but large. The constant risk model was the best
Bayesian model in terms of DIC (Table 2). The socioeco-
nomic inequalities did not seem to affect the spatial varia-
tions of colon-rectum cancer incidence in Département
Isère (β = -0.001 [-0.011; 0.009]) (Table 4).
Bladder cancer
Spatial heterogeneity (p < 0.001) without “naive” autocor-
relation (I = 0.001; p = 0.346) and “true” autocorrelation
Table 2 Deviance information criteria and empirical variances of the Bayesian models (with their 95 % credible intervals, CI)
Deviance information criteria Empirical variances (95 % CI)
Cancer α(+βχι) α + Vi(+βχι) α + Ui(+βχι) α + Ui + Vi(+βχι) su
2 sv
2
Without covariate
Lung 2172.8 2071.2 2082.8 2068.3 0.031 (0.004; 0.498) 0.057 (0.031; 0.085)
Prostate 2765.3 2631.4 2585.4 2589.2 0.008 (0.003; 0.019) 0.617 (0.310; 0.998)
Colon-rectum 1929.0 1931.0 1930.3 1932.5 0.0091 (0.002; 0.022) 0.0354 (0.007; 0.180)
Bladder 1374.6 1373.2 1371.0 1371.4 0.018 (0.005; 0.052) 0.241 (0.025; 1.015)
With covariate
Lung 2016.5 2007.2 2009.9 2007.9 0.066 (0.013; 0.374) 0.011 (0.002; 0.030)
Prostate 2736.4 2630.2 2585.7 2588.5 0.007 (0.017; 0.002) 0.577 (0.261; 0.981)
Colon-rectum 1930.7 1933.1 1932.0 1933.3 0.007 (0.002; 0.024) 0.006 (0.002; 0.143)
Bladder 1368.3 1371.0 1367.4 1370.3 0.017 (0.0035; 0.056) 0.195 (0.030; 2.529)
(+βχι) in case of additional covariate - U: Autocorrelation - V : heterogeneity - su
2: Autocorrelation empirical variance - sv
2: Heterogeneity empirical variance – X
Townsend index components
Table 3 The method of spatial analysis: summary on heterogeneity, clustering, and high-risk clusters
Cancer Potthoff-Whittinghill Moran I EBI Poisson SpODT SATSCAN HBSM
Without covariate
Lung Heterogeneity No clustering Clustering No clustering No cluster Two clusters Heterogeneity and clustering
Prostate Heterogeneity Clustering Clustering No clustering Six clusters Five clusters Only clustering
Colon rectum No heterogeneity No clustering No clustering No clustering No cluster Two clusters No heterogeneity and no clustering
Bladder Heterogeneity No clustering Clustering No clustering One cluster No cluster Only clustering
With covariate
Lung --- --- No clustering No cluster No cluster Only heterogeneity
Prostate --- --- No clustering Five clusters No cluster Only clustering
Colon rectum --- --- No clustering No cluster No cluster No heterogeneity and no clustering
Bladder --- --- No clustering One cluster No cluster Only clustering
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(I = 0.007; p = 0.05) were found for bladder cancer (Table 1).
SpODT detected starred clusters in the Centre-East of the
area (RR = 1.44, p < 0.01). SaTScan detected no clusters.
Taking into account the spatial structure of bladder
cancer cases, the best Bayesian model in terms of DIC
was the CAR model (Table 2; Fig. 6b). With the Town-
send index, SpODT detected a shrunk cluster. The
introduction of this index into the best Bayesian model
did not change a lot the DIC (Tables 2 and 3). In the
BYM models, variance sv
2 was greater than variance su
2
(Table 2). Mapping the relative risk according to CAR
model with adjustment on the Townsend index showed
that the socioeconomic inequalities had an impact on
the spatial variations of bladder cancer incidence in
Département Isère (β = 0.022 [0.003; 0.041]) (Fig. 6d;
Table 4).
Results of the multivariate analysis
Finally, the DICs of independent disease modeling, with
or without covariate, were not higher than those of the
Table 4 The method of spatial analysis: effect of the socioeconomic status on the spatial structure of cancer incidence
[regression coefficient with 95 % confidence intervals for Poisson models or credible intervals for HBSM]
SpODT SATSCAN HBSM
α + βχι α + Vi + βχι α + Ui + βχι α + Ui + Vi + βχι
Lung --- --- 0.059 [0.050; 0.069] 0.067 [0.054; 0.080]a 0.065 [0.053; 0.077] 0.068 [0.055; 0.080]
Prostate 5 clusters --- -0.017 [-0.023; -0.011] -0.010 [-0.021; -0.0005] -0.012 [-0.022; -0.001]a -0.011 [-0.021; -0.0009]
Colon rectum --- --- -0.001 [-0.011; 0.009]a 0.0003 [-0.011; 0.012] 0.0004 [-0.010; 0.011] 0.0007 [-0.011; 0.013]
Bladder 1 cluster --- 0.023 [0.007; 0.039] 0.023 [0.004; 0.043] 0.022 [0.003; 0.041]a 0.024 [0.003; 0.045]
aBest Bayesian model in term of DIC, βχι additional covariate - U: Autocorrelation - V : heterogeneity X Townsend index components
Fig. 3 Clusters of prostate cancer cases found by different methods: a SpODT clusters without adjustment on the Townsend index, b SaTScan
clusters without adjustment on the Townsend index, c Mapping of the log relative risks estimated by BYM model using hierarchical Bayesian
spatial modeling without adjustment on the Townsend index. Four risk levels were considered (lightest to darkest color), d SpODT clusters with
adjustment on the Townsend index
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multivariate BYM models. The multivariate BYM model
with fixed effects was the best model (Table 5). The
correlations between the effects of these cancers were very
important in the case of the pair lung-bladder cancers
(Table 6). The mapping of the diseases led to less smooth-
ing than with the univariate BYM models. However,
mapping the relative risk with the multivariate approach
showed no longer the clusters, not even those of prostate
cancer cases (Additional files 1–6).
Discussion
Different methods of spatial analysis suitable for cluster
detection and epidemiological monitoring in small areas
were used here to: i) describe spatial heterogeneity and
autocorrelation; ii) evaluate the impact of heterogeneity
on global spatial autocorrelation; and: iii) search for an
effect of the socioeconomic status on geographical dif-
ferences in cancer incidence by analyzing the overall
spatial structure or detecting high-risk areas. More
precisely, the work aimed at examining whether
deprivation is an explanatory or a confusion factor of
the spatial distribution of some cancers. This study high-
lights the importance of using both global [42] and local
methods of cluster detection taking into account hetero-
geneity [43]. “Naive” spatial autocorrelation and hetero-
geneity were found only with prostate cancer data. The
adjusted Moran’s I method [43] detected mainly a spatial
autocorrelation in lung and bladder cancer as well as in
prostate cancer by taking into account the spatial het-
erogeneity. In all cancers, “true” Moran’s I value was
greater than “naive” Moran I value. This shows that it is
important to include small spatial units in the calcula-
tion of spatial units in the calculation of spatial test sta-
tistics to be able to detect spatial autocorrelation.
SpODT is an approach recently applied to spatial
distribution of cancer risk. Like SaTScan, one advantage
of SpODT is its ability to overcome the administrative
boundaries; another is that its implementation does not
require the use of a proximity matrix, which avoids the
a b
c d
Fig. 4 Mapping of prostate cancer: a geographic variations of standardized incidence ratio, b Mapping of the log relative risks estimated by CAR
model using hierarchical Bayesian spatial modeling without adjustment on the Townsend index, c Mapping of the log relative risks estimated by
heterogeneity model using hierarchical Bayesian spatial modeling without adjustment on the Townsend index, d Mapping of the log relative
risks estimated by CAR model using hierarchical Bayesian spatial modeling with adjustment on the Townsend index. Four risk levels were
considered (lightest to darkest color)
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problems related to the choice of this matrix (as in
HBSM) [12]. According to the algorithm stopping criteria,
these two methods require sensitivity analyses. With
SaTScan, the optimal clusters were found after sensitivity
analyses regarding the size of the window. In the previous
literature, few authors have mentioned these sensitivity
analyses or the search for optimal parameters. Depending
on the user settings, the lack of a sensitivity analysis
is not in favor of a method’s reproducibility [44]. In disease
mapping, Bayesian smoothing remains important because
it allows taking into account spatial and non-spatial effects
in risk estimation [1, 4, 45]. In small-area studies, prob-
lems of robustness of the estimates can be overcome by
the use of hierarchical Bayesian spatial modeling; this
warrants a better understanding of the risk levels in spatial
epidemiology. In a simulation study, Aamodt et al. [32]
have shown that BYM model is better than SaTScan
for local cluster detection in case of high relative risks
[46]. Bayesian models allow both global and local detection
through criteria such as the variance of the autocorrelation,
heterogeneity components, and DIC. The multivariate
disease mapping approach through joint modeling [15, 34,
36, 37] provides also a considerable improvement of spatial
analysis by including information on correlations between
diseases and by reducing smoothing effects. The present
study shows the specificities of each method that will be
discussed according to the results by cancer type.
The case of colon-rectum cancer (where global methods
found neither heterogeneity nor spatial autocorrelation)
allowed an evaluation of local clustering methods. In this
case, the use of a spatial model is superfluous; indeed, all
the methods agreed on the absence of clusters of colon-
rectum cancers. Only SaTScan detected clusters of high
risk with RRs <1.5 when the analysis was carried out
without covariate. Guttmann et al. [7] have shown in a
simulation that the performance of SaTScan increased
with the size of the population. Likewise, in small areas
when Commune is a proxy for patient exact location, our
results corroborate those of Lemke et al., Jeffery et al., and
Ozonoff et al. [32, 47, 48]. These studies demonstrated
that the power of detecting clusters with SaTScan de-
creased together with the level of spatial resolution. The
a b
c d
Fig. 5 Clusters of colon-rectum cancer cases found by different methods: a geographic variations of standardized incidence ratio, b Mapping of
the log relative risks estimated by the CAR model using hierarchical Bayesian spatial modeling without adjustment on the Townsend index,
c SaTScan clusters without adjustment on the Townsend index (2 clusters of high risk), d Mapping of the log relative risks estimated by the
heterogeneity model using hierarchical Bayesian spatial modeling without adjustment on the Townsend index (lightest to darkest color)
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shape of the cluster was also discussed by Goujon-Bellec
et al. [49] who found that the elliptic scan method seems
more appropriate than the circular scan method in detec-
ting clusters of rare diseases over large regions. With
simulation studies, other authors, such Aamodt et al. [46]
have found that SaTScan was more efficient than BYM
model in detecting clusters with relatively low relative
risks. This was corroborated in colon-rectum cancer. The
HBSM confirmed its ability to detect a homogeneous risk
with colon-rectum cancer and seemed to be less affected
by population size, spatial resolution, or cluster shape.
Furthermore, the use of an additional covariate (here, the
Townsend index) reduced greatly the performance of
SaTScan in terms of specificity [50].
In the case of prostate cancer, all the methods con-
verged to the same conclusion. The global clustering
methods found a spatial autocorrelation and a spatial
heterogeneity and all the local methods showed coherent
clusters. SaTScan failed to detect an effect of the socio-
economic status. SpODT as well as the univariate HBSM
detected coherent clusters. Our results with prostate
cancer data raised the problem of edge effects in local
cluster detection as previously found by Johnson [17].
An edge effect can be defined as an impact on the
Fig. 6 Clusters of bladder cancer cases found by different methods: a geographic variations of standardized incidence ratio, b Mapping of
the log relative risks estimated by the CAR model using hierarchical Bayesian spatial modeling without adjustment on the Townsend index,
c Mapping of the log relative risks estimated by the heterogeneity model using hierarchical Bayesian spatial modeling without adjustment on
the Townsend index, d Mapping of the log relative risks estimated by the CAR model using hierarchical Bayesian spatial modeling with
adjustment on the Townsend index
Table 5 Deviance information criteria for independent modeling and multivariate modeling (M-based BYM) of the Bayesian models
Deviance information criteria
Modeling α(+βχι) αþ Vi þβχιð Þ αþ Ui þβχιð Þ αþ Ui þ Vi þβχιð Þ M-based BYM
with fixed effects
M-based BYM
with random effects
Without covariate 8141.7 8006.8 7969.5 7961.4 6947.84 7131.05
With covariate 8051.9 7941.5 7895 7900
(+βχι) in case of additional covariate - U: Autocorrelation - V : heterogeneity X Townsend index components
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results of features specific to the boundaries of the study
area, such as spatial censoring. Precisely, some subjects
may not be observed because they are out of the study
area and thus excluded from the spatial analysis [4].
Indeed, the cluster of prostate cancer cases detected by
SaTScan in the center of the area is probably erroneous
because other clusters were also located at the bounda-
ries of that area. Actually, Guttmann et al. [42] have
shown that false clusters are numerous when edge
effects are important. To correct these effects, the area
under sensitivity analyses may be extended to other
neighboring areas (here, an extension from Département
Isère to the whole Rhône-Alpes Region). The use of
more homogeneous spatial units than the current
Communes, such as the French “Ilots Regroupés pour
l’Information Statistique” (IRIS), may also eliminate or
reduce the edge effects [51]. Little and Rubin have also
proposed to solve this problems by the use of methods
that consider the external areas as missing data [4]. We
may mention here that SpODT was able to detect more
precise clusters than SaTScan, especially when the Town-
send index was taken into account in presence of autocor-
relation. Poisson model and HBSM found that larger
socioeconomic inequalities decreased the incidence of
prostate cancer. In fact, deprived patients are often diag-
nosed at symptomatic stages, a fact that has been precisely
detected by SpODT in the Southwestern part of Isère.
This should be kept in mind because, in deprived people,
other cancers, such as skin melanoma and breast cancer
are often diagnosed at advanced stages [52].
In the cases of lung and bladder cancers, EBI showed
“true” spatial autocorrelation while Moran’s I test failed
to find autocorrelation. These results highlight the im-
portance of taking into account the heterogeneity in
small areas when attempting to identify the spatial pat-
tern of a disease. Contrarily to SaTScan, SpODT did not
find clusters of lung cancer. Lung cancer results showed
that a lower DIC (with vs. without introducing the
Townsend index into the model) has identified an effect
for that index on the geographical variations of the inci-
dence in terms of spatial heterogeneity. In lung cancer,
the Townsend index influenced greatly the randomcom-
ponent whereas, in the bladder cancer, it was spatial
autocorrelation that influenced the spatial analysis. The
Poisson model and the univariate HBSM coefficient have
shown that, in these two cancers, the incidence increases
together with the socioeconomic inequalities. In the
specific case of lung cancer, the socioeconomic status
seemed to be a surrogate for various lifestyle factors
(e.g., alcohol/tobacco consumption). Thus, as in previous
studies, the socioeconomic status should not be over-
looked, as a risk factor, in examining lung cancer etiology
[53]. One, now classical observation, is that bladder cancer
shares common risk factors with lung cancer (e.g., tobacco
consumption). This was shown by Cassetti and al. [18] in
a spatial study in Umbria, Italy. The multivariate modeling
found also a correlation between these two cancers
(posterior mean estimation: 0.6). In terms of DIC, the
multivariate BYM model was the best model. These
results corroborate those of Martinez-Beneito [20] who
recommended multivariate disease mapping models to
epidemiologists interested in the spatial variations of
several diseases. Changes in the DIC with HBSM may thus
be used to identify the most credible spatial model vs.
other competing spatial competing models and detect the
cluster of high risk. Indeed, we have used the DIC on
Colonna and Sauleau [5] updated data to choose the
best univariate Bayesian model and found similar results.
However, some covariates and spatial patterns may be
mixed up with the random effects; their inclusion in a
spatial analysis can lead to biased estimates of the fixed
effects [54].
Using CAR models, some authors such as Reich et al.
or Hughes and Haran [55, 56], advise the use of a model
without confounding random effects even if its DIC is
greater than that of the usual spatial model when the
goal is to study the association between any covariate
and the disease under study. Here, in all the approaches
we used, we did not check the existence of spatial
confounding.
Limitations
In this empirical assessment of the efficacy of cluster
detection methods, the results were consistent across all
methods only in the case of prostate cancer. This raises
questions in terms of power and precision of spatial
cluster detection methods and suggests that power and
precision would increase together with the event rate.
However, checking both these hypotheses and assessing
the efficacy of the discussed methods in other plausible
epidemiological situations require analyses conducted in
a systematic way. These limitations could be solved
properly by simulation studies.
Conclusion
The present methodological and comparative study on the
performance of cluster detection methods in oncology
was able to show the importance of using a variety of
methods not only to find coherent spatial clusters but also
Table 6 Posterior means of the between-disease correlation
matrix for the M-based BYM model with fixed effects
Cancer Lung Prostate Bladder Colon-rectum
Lung 1
Prostate 0.03 1
Bladder 0.60 0.29 1
Colon-rectum 0.40 0.14 0.39 1
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to determine the influence of a given factor on the geo-
graphical distribution of cancer incidence. The study is a
practical example of cluster identification in presence of
heterogeneity and unknown common factors. It demon-
strates that it is possible to obtain a quantitative estima-
tion of the effect of the socioeconomic status on the
differences in cancer incidence, especially through the
Bayesian approaches able to integrate prior information.
The multivariate spatial modeling is recommended to
map several diseases and take into account their potential
links.
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